SavedAdd your journal

Journals / Viral Hepatitis Journal / 2015 / Cilt: 21 - Sayı: 2

Kronik Hepatit C Tedavisi Kaynaklı Deri Döküntüsü: İki Olgu Sunumu

Chronic Hepatitis C Treatment-Related Skin Rash: A Report of Two Cases

TUĞBA ARSLAN GÜLEN
AYFER İMRE
Pages
59–61
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this report, we present two patients who developed skin reactions during anti-HCV treatment; one of the patients recovered without interrupting therapy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Pegylated interferon alpha and ribavirin are used as combination therapy in chronic hepatitis C treatment and may cause various cutaneous reactions.
📊
Key Findings & Data:Some skin rashes improve with oral antihistamines and topical therapy, whereas others need to discontinue the treatment.
💡
Conclusion & Impact:In this report, we present two patients who developed skin reactions during anti-HCV treatment; one of the patients recovered without interrupting therapy.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Pegylated interferon alpha and ribavirin are used as combination therapy in chronic hepatitis C treatment and may cause various cutaneous reactions. Some skin rashes improve with oral antihistamines and topical therapy, whereas others need to discontinue the treatment. In this report, we present two patients who developed skin reactions during anti-HCV treatment; one of the patients recovered without interrupting therapy.

Özet

Pegile interferon alfa ve ribavirin, kronik hepatit C tedavisinde kullanılan kombinasyon tedavisi olup, çeşitli kutanöz reaksiyonlara neden olabilmektedir. Deri lezyonlarının bir kısmı oral antihistaminik ve topikal tedavi ile düzelme gösterirken, diğer bir kısmında tedaviye ara vermek gerekmektedir. Bu raporda, hepatit C tedavisi sırasında deri döküntüsü gelişen ve birinde tedaviye ara vermeksizin düzelme görülen iki hasta sunulmuştur.

🔖

Cite This Article

GÜLEN, T. A., İMRE, A. (2015). Kronik Hepatit C Tedavisi Kaynaklı Deri Döküntüsü: İki Olgu Sunumu. Viral Hepatitis Journal, Cilt: 21 - Sayı: 2, 59–61. https://ajindex.com/articles/332806

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Cacoub P, BourliEre M, Lübbe J, Dupin N, Buggisch P, Dusheiko G, HEzode C, Picard O, Pujol R, Segaert S, Thio B, Roujeau JC. Dermatological side effects of hepatitis C and its treatment: Patient management in the era of direct-acting antivirals. J of Hepatol. 2012; 56: 455-463
  2. Gurbuz Y, Tutuncu EE, Ozturk DB, Baylak A, Sencan I. Kronik Hepatit C tedavisini takiben gelişen cilt bulguları; iki olgu sunumu. Viral Hepatit Derg. 2011; 17: 84-87
  3. Lübbe J. Dermatological side effects. Hot Topics in Viral Hepatitis. 2008; 9: 29-35
  4. Moore MM, Elpern DJ, Carter DJ. Severe, generalized nummular eczema secondary to interferon alpha-2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus infection. Arch Dermatol. 2004; 140: 215-217
  5. Hashimoto Y, Kanto H, Itoh M. Adverse skin reactions due to pegylated interferon alpha 2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus. J Dermatol 2007; 34: 577-582
  6. Toney RC, Agrawal Rad M, Loeffert M. Injection site bullous eruption and generalized rash induced by pegylated interferon treatment for hepatitis C. Gastroenterol Hepatol. 2009; 5: 715-719
  7. Veluru C, Atluri D, Chadalavada R, Burns E, Mullen DK. Skin rash during chronic hepatitis C therapy. Gastroenterol Hepatol. 2010; 6: 323-325
  8. Sookoian S, Neglia V, Castaño G, Frider B, Kien MC, Chohuela E. High prevalence of cutaneous reactions to interferon alpha plus ribavirin combination therapy in patients with chronic hepatitis C virus. ArchDermatol. 1999; 135: 1000-1001
  9. Patrk I, Morovie M, Markulin A, Patrk J. Cutaneous reactions in patients with chronic hepatitis C treated with peginterferon and ribavirin. Dermatology. 2014; 228: 42-46
  10. Dereure O, Raison-Peyron N, Larrey D, Blanc F, Guilhou JJ. Diffuse inflammatory lesions in patients treated with interferon alfa and ribavirin for hepatitis C: a series of 20 patients. Br J Dermatol. 2002; 147: 1142-1146
  11. Basaranoglu M, Celebi S, Karaaslan H, Demir A. Case study on drug-related adverse effects of hepatitis C therapy. Adv Ther. 2006; 23: 769-771.